10.10.2016
- As part of a “broader, global strategic plan” to centralize control over its drug discovery programs and contain costs, Swiss drugmaker Novartis said it will close R&D sites in...
04.10.2016
- Bayer and Evotec have signed a five-year multi-research pact to develop multiple clinical candidates to treat chronic kidney diseases. Both of the German companies will contribute...
02.09.2016
- During the last two decades the pharmaceutical industry was forced to undertake significant structural changes to address mounting challenges from strict regulatory policies, lower...
19.07.2016
- Bayer and X-Chem Pharmaceuticals have expanded their global drug discovery collaboration, which was launched in 2012 and spans multiple therapeutic areas and target classes. The...
07.03.2016
- French pharmaceutical company Ipsen is paying up to $855 million for the rights to Exelixis’ cancer drug Cabozantinib. Under the deal, Exelixis gains exclusive commercialization...
02.10.2015
- Johnson Matthey has further boosted its fine chemicals arm with the acquisition of the Pharmorphix solid form research business based at Cambridge, England, from Sigma-Aldrich. The...
01.04.2015
- Fujifilm announced that it will acquire Cellular Dynamics International (CDI) for $307 million via an all-cash tender offer to be followed by a second step merger. Under the terms...
21.01.2015
- CPhI Worldwide has announced the launch of a new advisory board, consisting of the following industry experts who provide a wide expertise portfolio: Alan Sheppard, Principal...
